Smith & Nephew plc
Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices worldwide. The company offers knee implant products for knee replacement procedures; hip implants for the reconstruction of hip joints; and tra…
Medical - Devices
GB, Watford [HQ]
FA
Fundamental Analysis · Most Recent Quarter
A dedicated fundamental analysis might help you to get a quick overview
of the
financial stability. It is important to understand the
FA Algorithm
and the criterias before valuing it as a top-tier resource.
1
Financial Health
| Metric | Q3 | Q4 | Δ in % | |
|---|---|---|---|---|
| Current Ratio | 0.00 | 1.77 | 1.77 | |
| Debt/Assets | n.A. | n.A. | n.A. | |
| Debt/Equity | n.A. | n.A. | n.A. | |
| Net Debt/EBITDA | -67.24 | 3.28 | 10.01 | |
| Naive Interpretation | member | |||
2
Per Share
| Metric | Q3 | Q4 | Δ in % | |
|---|---|---|---|---|
| Book Value | 0.23 | 5.98 | 5.96 | |
| Cash | 0.23 | 0.35 | 0.35 | |
| Capex | -101.84 | -0.30 | -0.15 | |
| Free Cash Flow | 104.70 | 0.27 | 0.13 | |
| Revenue | 103.94 | 3.28 | 1.61 | |
| Naive Interpretation | member | |||
3
Profitability
| Metric | Q3 | Q4 | Δ in % | |
|---|---|---|---|---|
| Gross Margin | -3.66 | 0.68 | 0.71 | |
| Operating Margin | 10.07 | 0.16 | 0.14 | |
| ROA | 103.48 | < 0.005 | < 0.005 | |
| ROE | 103.48 | 0.02 | < 0.005 | |
| ROIC | 202.97 | 0.06 | 0.02 | |
| Naive Interpretation | member | |||
4
Valuation
The "Valuation Entry" for the Focus of SNNUF is permitted for members.
5
Growth
The "Growth Entry" for the Focus of SNNUF is permitted for members.
6
Leverage & Liquidity